Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels.
about
Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resiliencePharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.Adrenergic pharmacology and cognition: focus on the prefrontal cortexLack of effect of the alpha2C-adrenoceptor Del322-325 polymorphism on inhibition of cyclic AMP production in HEK293 cells.JP-1302: a new tool to shed light on the roles of alpha2C-adrenoceptors in brain.A four amino acid deletion polymorphism in the third intracellular loop of the human alpha 2C-adrenergic receptor confers impaired coupling to multiple effectors.Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization.In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice.α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapyPhysiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough.Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders.Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention.Desipramine potentiation of the acute depressant effects of ethanol: modulation by alpha2-adrenoreceptors and stressPostsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior.Resilience to meet the challenge of addiction: psychobiology and clinical considerations.Adrenal adrenoceptors in heart failure.Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum.Alpha-adrenoceptor modulation in central nervous system trauma: pain, spasms, and paralysis--an unlucky triad.Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors.Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review.Neurobiological mechanisms of stress resilience and implications for the aged population.Alpha2C-adrenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence.Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans.Immunohistochemical localization of α2-adrenergic receptors in the neonatal rat cochlea and the vestibular labyrinth.Alpha2A and alpha2C-adrenoceptor regulation in the brain: alpha2A changes persist after chronic stress.Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models.
P2860
Q22337457-0C422B0E-3EAC-4D41-B11E-AAD498F537E2Q24681582-3D519D63-3E8C-4A6C-8D9F-7890EDCEFF3EQ24684217-BCF90EF9-C038-4A63-A9EC-4699A0F4D1E5Q30477206-E92D168A-8CBF-4C9F-82A2-A18E44BDAA90Q30497070-274FE740-7C5D-4745-854F-B1B639116185Q33901100-2BC1B385-86EC-4367-8374-C684CD842067Q33923585-B16C1C9E-E9D3-40D5-B923-FDCB77A92DDDQ34292427-035DC1BF-B61A-456B-A0DE-A6ED8DEDFBC3Q34295208-2EABA031-FE62-42C7-A985-DF864F311A89Q34744859-721630DE-22E6-4DAB-9205-CACFB3FEBD5EQ35596567-0375DC70-29E3-4554-89D0-268D688D7288Q35708618-6BD18A37-746B-4A49-B6AF-32EF37323163Q37076644-F928292F-3C80-4924-8258-74DF6C020261Q37307260-A838B55A-D7BF-4CE3-8258-5E17AB2AB7D1Q37386356-45EC3206-2100-44C7-8D9A-41DC4B3F5D65Q38234911-8B4CEF9D-FF47-4436-B71E-82C6E4632C14Q38297689-D577CEED-3D27-4703-8663-B309990EC194Q38302539-36607340-7477-4707-9868-ABE85310DF77Q38316708-9711D9E1-777A-4965-A5E1-F863C7B53BDBQ38635337-417574A8-FFC0-439C-8418-BC4A9925ACA8Q38861612-46CA971F-1FB3-44FA-B989-E7A579AAD23CQ39311440-EABD31EC-4F0F-41EA-8C3B-C2CB58234396Q39894765-FBCDA29F-8724-4B0E-9FC8-58F85516E4BEQ43797541-10FAD20C-EF48-4C8C-99EB-A69B337BD845Q47704222-7983CE8E-4A20-4A70-99B2-74E5DD33823CQ48017116-721C6334-F8C9-46DC-BCF9-E769A0953F74Q50952384-E210787B-2724-4DF1-82D4-EFFD816002A4
P2860
Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Genetic alteration of the alph ...... plasma corticosterone levels.
@en
Genetic alteration of the alph ...... plasma corticosterone levels.
@nl
type
label
Genetic alteration of the alph ...... plasma corticosterone levels.
@en
Genetic alteration of the alph ...... plasma corticosterone levels.
@nl
prefLabel
Genetic alteration of the alph ...... plasma corticosterone levels.
@en
Genetic alteration of the alph ...... plasma corticosterone levels.
@nl
P2093
P356
P1433
P1476
Genetic alteration of the alph ...... plasma corticosterone levels.
@en
P2093
Haapalinna A
Kobilka BK
Lähdesmäki J
MacDonald E
Pelto-Huikko M
Rybnikova E
Sallinen J
Scheinin M
Viitamaa T
P2888
P304
P356
10.1038/SJ.MP.4000543
P407
P577
1999-09-01T00:00:00Z